U.S. Trade Distributors Stock News

Q2 Holdings, Inc. reported past second-quarter 2026 results showing sales of US$219.77 million and net income of US$29.86 million, with both revenue and earnings higher than a year earlier. The company also raised its full-year 2026 revenue and adjusted EBITDA guidance, citing strong demand for its digital banking and AI-powered products. We’ll now examine how the raised full-year guidance and AI-driven product momentum influence Q2 Holdings’ existing investment narrative. The future of work...

NPK International Inc. recently reported its second-quarter and first-half 2026 results, with sales rising to US$81,590,000 and net income to US$11,970,000 for the quarter, and simultaneously raised full-year 2026 revenue guidance to a range of US$313,000,000 to US$323,000,000. Alongside these results, the company is committing capital to expand Louisiana manufacturing capacity and grow its rental fleet, signaling operational confidence and a focus on supporting longer-term demand. Next,...

Turning Point Brands (TPB) recently affirmed its capital return approach as the Board declared a regular quarterly dividend of $0.08 per share, payable on October 9, 2026, to shareholders of record on September 18. See our latest analysis for Turning Point Brands. The dividend affirmation comes after a weak run for Turning Point Brands’ share price, with the stock down 14.6% over the past 30 days and 32.3% year to date, even as its 3 year total shareholder return of about 201% points to a...

In the past quarter, Carvana Co. reported record second-quarter 2026 results, with revenue rising to US$7.38 billion from US$4.84 billion and net income increasing to US$310 million from US$183 million a year earlier, while also expanding same-day vehicle delivery to customers in the Fort Myers area. Despite these record figures, Carvana’s cautious full-year adjusted EBITDA guidance contrasted with its strong operational performance, raising questions about how management is balancing rapid...

Why Kymera Therapeutics Stock Is Back In Focus After A C-suite Change Kymera Therapeutics (KYMR) is in focus after appointing Terence Rooney, MD, as Chief Medical Officer, a change that puts fresh attention on how the company plans its future clinical development work. See our latest analysis for Kymera Therapeutics. Kymera Therapeutics shares trade at US$103.40 after short term share price weakness, with the stock down 3.37% over one day and 9.46% over 30 days, although a 28.11% 90 day share...

Pacira BioSciences recently transitioned its investigational knee osteoarthritis gene therapy PCRX-201 to a scalable U.S.-based commercial manufacturing process and began enrolling patients into Part B of its Phase 2 ASCEND trial, while keeping the program on schedule. This progress not only advances one of Pacira’s highest-profile pipeline assets, supported by RMAT and ATMP designations, but also showcases the broader commercial potential of its high-capacity adenovirus gene therapy...

PPL (PPL) is back in focus after spending more than US$40 million with Blackstone Infrastructure on over 500 acres in Luzerne County for potential data center power plants. See our latest analysis for PPL. The latest data center power plans arrive while PPL’s short term share price performance has been weaker, with the stock down over the past quarter. However, the 3 year and 5 year total shareholder returns of 49.34% and 44.02% point to a stronger longer term record. If you think the data...

In late July 2026, JPMorgan Chase & Co. raised fresh funding through a wide range of new callable, unsecured fixed‑income notes and by completing multiple earlier bond offerings across maturities from 2028 to 2056. Alongside this busy debt calendar, the bank’s record Q2 profit, strong analyst sentiment, and ongoing build‑out in active ETFs and private banking reinforced its image as a diversified franchise using bond markets to support long-term growth initiatives. With JPMorgan pairing...

Big swings in stocks like Amazon, Apple, Coinbase and Roblox have pushed volatility and trading volumes back into the spotlight. When mega caps move sharply, the impact often spreads across the market and can reshape activity in options, ETFs and trading platforms. That creates fresh opportunities and risks for investors who care about how actively a stock trades, not just what it earns. This article looks at 3 stocks that are closely tied to this surge in volatility and are positioned to...

Harmony Biosciences Holdings has delivered a 30.8% total return over the past 5 years. However, recent share price softness and a strong overall value score suggest the stock may still be pricing in a relatively cautious view. The question for investors is whether the recent drift in performance lines up with what the broader valuation checks are implying. Over 5 years, Harmony Biosciences Holdings has returned 30.8%, which points to a moderate payoff for investors who stayed invested over...

Intuitive Surgical stock has dropped about 37.1% year to date, yet the current checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to some undervaluation while traditional market multiples suggest the shares screen expensive. Year to date, Intuitive Surgical is down 37.1%, which puts recent pricing under pressure even after a 4.7% gain over the last week. Expectations around long term procedure growth and new platforms such as da Vinci 5 can support...

Lear (NYSE:LEA) filed a new universal shelf registration, expanding its capacity to issue securities in the future. The company also launched a $252 million common stock offering tied to its Employee Stock Ownership Plan. Lear is a major automotive supplier focused on seating and electrical distribution systems, so capital flexibility can matter for product programs with large up front costs. The new shelf registration gives the company additional tools to access funding as auto...

Li Auto stock has had a difficult three years, with the share price down about 70.3%, yet current checks suggest the valuation now sits close to what most models consider fair. The Discounted Cash Flow (DCF) intrinsic value estimate is in line with the current market price and the main market based metrics also point to Li Auto trading at about the right level. Over the past three years Li Auto has declined 70.3%, which puts recent short term gains into the context of a longer period of weak...

McKesson (MCK) recently declared a quarterly dividend of US$0.94 per share, payable on October 1, 2026, with the ex dividend and record dates set for September 1, 2026. Investors may now reassess the stock’s income profile. See our latest analysis for McKesson. At a share price of US$856.19, McKesson’s recent 30 day share price return of 11.47% and 1 year total shareholder return of 23.02% indicate strengthening momentum ahead of the upcoming earnings report and this dividend. If this kind of...

Rockwell Automation (ROK) recently reported quarterly results that surpassed analyst expectations, with revenue and earnings supported by strong organic growth and a raised full year outlook that set it apart from industrial automation peers. See our latest analysis for Rockwell Automation. After the earnings beat and guidance raise, Rockwell Automation's share price has moved to $480.08, with a 90 day share price return of 17.83% and a 1 year total shareholder return of 41.33%. This suggests...

In the second quarter of 2026, Boeing reported revenue of US$24,560 million and a net loss of US$444 million, both improving from a year earlier. The company’s progress in ramping 737 MAX production and expanding manufacturing capacity, particularly in Mesa, Arizona, underpins its efforts to strengthen operations alongside financial recovery. We’ll now examine how Boeing’s improving earnings and accelerating 737 MAX delivery ramp influence the company’s broader investment narrative and...

Roper Technologies (ROP) has drawn fresh attention after reporting second quarter 2026 sales of US$2.11b and net income of US$1.17b, alongside completing a large, multi quarter share repurchase program. See our latest analysis for Roper Technologies. Roper Technologies’ recent earnings release and completion of its multi quarter buyback have coincided with a 7.6% 1 month share price return and a 9.4% 3 month share price return, although the 1 year total shareholder return is down 27.1%. This...

T-Mobile US stock has given investors a solid 34.2% gain over the past three years, yet the broader valuation checks suggest it now sits closer to a fair value zone rather than looking clearly cheap or clearly expensive. Over the past three years, T-Mobile US has returned 34.2%, which points to meaningful gains already baked into the share price. Premium plan adoption and heavier use of AI across the network can support expectations for strong cash generation, while service outages and...

Energizer Holdings is coming off a difficult stretch for long term shareholders, with the stock price down about 36.8% over the past five years, yet the current valuation checks still lean on the cheap side. For investors, that mix of weak historical returns and a relatively favorable pricing picture raises the question of whether the stock offers value or simply reflects underlying business challenges. Over the last five years, Energizer Holdings shares have declined roughly 36.8%, which...

Direct to consumer GLP-1 weight loss drugs are starting to reshape how money flows through large cap US retail and pharmacy chains. With employers pulling back on coverage, recurring monthly prescriptions are moving closer to the checkout counter and away from traditional insurance channels. That shift could change which companies win on store traffic, loyalty programs and cross selling. This article looks at three large US stocks from a retail and pharmacy screener that are exposed to this...

Johnson Controls International plc recently reported its fiscal third-quarter and nine-month 2026 results, with revenue rising to US$6,614 million for the quarter and net income reaching US$749 million, alongside higher basic and diluted earnings per share from continuing operations at US$1.23. Beyond the headline growth, management pointed to surging demand for data center and thermal-management systems, backed by a record backlog and a growing pipeline in cooling distribution units and...

In late July 2026, Ardelyx was reported to be on track for higher quarterly revenues and a smaller loss per share year over year, even as analysts cut their earnings estimates and flagged a negative Earnings ESP ahead of the June-quarter results. This combination of improving headline metrics but increasingly cautious analyst expectations highlights a tension between operational progress and confidence in near-term earnings power. We’ll now examine how this growing analyst caution on...

Flowserve Corporation recently reported past second-quarter 2026 results showing sales of US$1,169.18 million versus US$1,188.09 million a year earlier, while net income increased to US$99.00 million from US$81.75 million, and it trimmed 2026 total sales growth guidance to approximately 3% but expects mid-single-digit total sales growth for the third quarter with net earnings similar to the second quarter, even with a higher tax rate. Despite slightly lower sales and a reduced full-year...

How Apollo Global Management Stock Fits Into The Current AI Debate Apollo Global Management (APO) has moved into the center of the AI conversation after publishing a white paper that links artificial intelligence adoption with slower wage growth, especially for lower paid workers. The paper highlights a gap in wage outcomes between occupations with high AI exposure and those with lower exposure following the rollout of tools such as ChatGPT. For investors looking at Apollo Global Management...